$150.73
-1.65-1.08%
At close: -
$150.88
0.150.10%
After Hours: Jun 18, 7:45 PM EDT
Johnson & Johnson issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
04/15/2025 | JNJ | Johnson & Johnson | FY | 2025 | $10.50 | $10.70 | $10.50 | $91.00B | $91.80B | $90.29B | Get Alert |
01/22/2025 | JNJ | Johnson & Johnson | FY | 2025 | $10.50 | $10.70 | $10.60 | $89.20B | $90.00B | $91.09B | Get Alert |
10/15/2024 | JNJ | Johnson & Johnson | FY | 2024 | $9.88 | $9.98 | $9.84 | $88.40B | $88.80B | $88.51B | Get Alert |
07/17/2024 | JNJ | Johnson & Johnson | FY | 2024 | $9.97 | $10.07 | $10.01 | $88.00B | $88.40B | $88.74B | Get Alert |
04/16/2024 | JNJ | Johnson & Johnson | FY | 2024 | $10.57 | $10.72 | $10.65 | $88.00B | $88.40B | $88.43B | Get Alert |
01/23/2024 | JNJ | Johnson & Johnson | FY | 2024 | $10.55 | $10.75 | $10.67 | $87.80B | $88.60B | $87.97B | Get Alert |
12/05/2023 | JNJ | Johnson & Johnson | FY | 2024 | $10.55 | $10.75 | $10.78 | — | — | — | Get Alert |
11/30/2023 | JNJ | Johnson & Johnson | FY | 2023 | $9.90 | $9.96 | $9.16 | — | — | — | Get Alert |
10/17/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.07 | $10.13 | $10.03 | $83.60B | $84.00B | $84.53B | Get Alert |
08/30/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.00 | $10.10 | $10.75 | $83.20B | $84.00B | $100.23B | Get Alert |
07/20/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.70 | $10.80 | $10.65 | $98.80B | $99.80B | $98.96B | Get Alert |
04/18/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.60 | $10.70 | $10.51 | $97.90B | $98.90B | $97.71B | Get Alert |
01/24/2023 | JNJ | Johnson & Johnson | FY | 2023 | $10.45 | $10.65 | $10.33 | $96.90B | $97.90B | $97.84B | Get Alert |
10/18/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.02 | $10.07 | $10.03 | $93.00B | $93.50B | $94.85B | Get Alert |
09/14/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.65 | $10.75 | $10.07 | — | — | — | Get Alert |
07/19/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.00 | $10.10 | $10.27 | $93.30B | $94.30B | $96.04B | Get Alert |
04/19/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.15 | $10.35 | $10.52 | $94.80B | $95.80B | $99.48B | Get Alert |
01/25/2022 | JNJ | Johnson & Johnson | FY | 2022 | $10.40 | $10.60 | $10.37 | $98.90B | $100.40B | $97.88B | Get Alert |
10/19/2021 | JNJ | Johnson & Johnson | FY | 2021 | $9.77 | $9.82 | $9.66 | $94.10B | $94.60B | $94.30B | Get Alert |
07/21/2021 | JNJ | Johnson & Johnson | FY | 2021 | $9.60 | $9.70 | $9.52 | $93.80B | $94.60B | $91.30B | Get Alert |
04/20/2021 | JNJ | Johnson & Johnson | FY | 2021 | $9.42 | $9.57 | $9.50 | $90.60B | $91.60B | $92.23B | Get Alert |
01/26/2021 | JNJ | Johnson & Johnson | FY | 2021 | $9.40 | $9.60 | $8.99 | $90.50B | $91.70B | $89.00B | Get Alert |
10/13/2020 | JNJ | Johnson & Johnson | FY | 2020 | $7.95 | $8.05 | $7.89 | $81.20B | $82.00B | $80.75B | Get Alert |
The most recent guidance for Johnson & Johnson (JNJ) was reported on April 15, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $10.50 to $10.70, compared to the estimated EPS of $10.50. Additionally, Johnson & Johnson forecasted revenue between $91.00B and $91.80B for the quarter.
Browse guidance and forecast on all stocks.